# Shiraz University of Medical Sciences

Organization · id `cardio:org-shiraz-university-of-medical-sciences` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01n3s4692](<https://ror.org/01n3s4692>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01n3s4692 by an exact name.

## The registry's words

- Sponsor name: Shiraz University of Medical Sciences
- Sponsor class: OTHER
- ROR name: Shiraz University of Medical Sciences

## Connected pages

- Sponsors: MSCs for Prevention of MI-induced HF (`cardio:ct-nct05043610`)
- Sponsors: Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy (`cardio:ct-nct06487949`)
- Sponsors: Ticagrelore Alone Post PCI (`cardio:ct-nct06509893`)

## Provenance

Content hash: d278b8d607f1e12b2ce848d4a2c4746929faf5eef4972e8ea4118ddeee6038d7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
